- GYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Gyre Therapeutics (GYRE) 8-K29 Sep 21FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII DeficiencyFinancial data
Company Profile